ArticleBMC medicine2026
The influence of age-dependent susceptibility on RSV transmission dynamics and immunisation population-level impact.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundRespiratory syncytial virus (RSV) causes substantial disease burden worldwide, disproportionately affecting infants and young children. Higher susceptibility to RSV infections in young children, interacting with age-varying contact patterns and risk of disease progression, could drive the age-related variations in disease burden, though the extent of the susceptibility differences, and their influence on transmission dynamics and immunisation impact remains unclear.
methodsWe developed an age-structured deterministic transmission model that integrated virological surveillance data, hospitalisations, and infection rates from the UK. We estimated age-dependent susceptibility coefficients for the 0- < 5 years, 5-59 year and ≥ 60 years by integrating a profile likelihood approach with Markov Chain Monte Carlo (MCMC)-based calibration. Models were fitted to weekly RSV-positive cases in Scotland and infection rate estimates for the UK population. Age-specific infection-hospitalisation ratios (IHRs) were derived by combining modelled infections with RSV-associated hospitalisations. We evaluated multiple paediatric immunisation scenarios by estimating infections and hospitalisations averted, and the number of individuals needed to immunise (NNI) to prevent one RSV hospitalisation at varying coverage and efficacy.
resultsWe estimated a susceptibility coefficient of 0.38 (95% CI 0.36-0.38) for 5-59 years, and 0.38 (0.20-0.40) for ≥ 60 years, relative to those under 5 years. The overall annual infection rate was 51.8%, with peaked in children aged 12-23 months (71.1%) and 0-2 months (63.7%) using the best-fitting model, showing a substantial shift in the age distribution compared to the base model. IHRs showed a U-shaped distribution, with the highest rates in infants aged 0-2 months and adults aged 75 and above. This model also projected a greater impact from immunisation programmes compared to the base model. For instance, an infant immunisation programme with 80% coverage and 80% efficacy against hospitalisation was projected to prevent 15.2% of hospitalisations, compared to 8.9% in the base model. Broader programmes, such as targeting 0-4-year-olds, resulted in larger reductions in hospitalisations (27.1%), while NNI increased as the programme expanded.
conclusionsThe increased RSV susceptibility in children under 5 years drives higher baseline transmission rates and disease burden in this subgroup, thereby influencing immunisation programme impact and efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.